Symbols

GNTA

Genenta Science·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About GNTA

Genenta Science S.P.A.

A biotech company that developing hematopoietic stem cell fund therapies for solid tumors

Industry

Biological Technology

Established Date

Listing Date

12/15/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.genenta.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

Via Olgettina No. 58, 20132 Milan, Italy

Business

Introduction

Genenta Science S.p.A. is established under the laws of the Republic of Italy. The company is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. The Company has developed a novel biological platform that involves the transfer of in vitro genes of therapeutic candidates into autologous hematopoietic stem/progenitor cells (" HSPCs ") to deliver immunomodulatory molecules directly to tumors by infiltrating monocytes/macrophages (Tie 2 Expressing Monocytes – "TEMs "). The company's technology aims to turn TEMs, which usually have an affinity for tumors and spread to tumors, into "Trojan horses" to fight cancer progression and prevent tumor recurrence.